Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
15.65
+0.03 (0.19%)
At close: Oct 7, 2025, 4:00 PM EDT
15.59
-0.06 (-0.38%)
After-hours: Oct 7, 2025, 4:41 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $635.63 million as of October 7, 2025. Its market cap has decreased by -70.45% in one year.
Market Cap
635.63M
Enterprise Value
-36.63M
1-Year Change
-70.45%
Ranking
Category
Stock Price
$15.65
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $635.63M, an increase of 64.96%. That is a compound annual growth rate of 9.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 634.41M | -1.06% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |